EM Vivas · Subarachnoid haemorrhage
Subarachnoid haemorrhage — diagnosis, grading and complications
A clinical viva on SAH diagnostics, grading, and secondary complications.
On this page
Study tools
Target exams
Interpretation
Reveal interpretationShowHide
Grading. Admission clinical condition is described with the Hunt and Hess and WFNS scales. The modified Fisher scale predicts symptomatic vasospasm — odds ratio 2.2 for grade 4 versus grade 0-1.[1][2] LP when CT is negative. CT sensitivity overall was 92.9% (100% within 6 hours). If CSF is examined, spectrophotometry was 100% sensitive versus 73% for visual inspection.[3][4] Nimodipine. Oral nimodipine 60 mg four-hourly reduced infarction (22 vs 33%) and poor outcome (20 vs 33%); in the Cochrane review oral nimodipine reduced poor outcome (RR 0.67) but intravenous nimodipine did not reach significance.[5][6] DCI. Defined by cerebral infarction on imaging and functional outcome, with clinical deterioration secondary. Induced hypertension is unproven — the only RCT showed no benefit and more serious adverse events. Statins (STASH) did not help, and ESO recommends against statins, magnesium and endothelin antagonists.[7][8][9][1]
References9ShowHide
- [1]Vergouwen MDI, Ramos-Pachon A, Terecoasa EO, et al. European Stroke Organisation (ESO), European Association of Neurosurgical Societies (EANS) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on aneurysmal subarachnoid haemorrhage. European stroke journal, 2026.PMID 42095754
- [2]Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery, 2006.PMID 16823296
- [3]Perry JJ, Stiell IG, Sivilotti ML, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study. BMJ (Clinical research ed.), 2011.PMID 21768192
- [4]Sjulstad AS, Brekke OL, Alstadhaug KB Visual inspection versus spectrophotometry for xanthochromia detection in patients with sudden onset severe headache-A diagnostic accuracy study. Headache, 2025.PMID 39087907
- [5]Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ (Clinical research ed.), 1989.PMID 2496789
- [6]Dorhout Mees SM, Rinkel GJ, Feigin VL, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. The Cochrane database of systematic reviews, 2007.PMID 17636626
- [7]Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke, 2010.PMID 20798370
- [8]Gathier CS, van den Bergh WM, van der Jagt M, et al. Induced Hypertension for Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial. Stroke, 2018.PMID 29158449
- [9]Kirkpatrick PJ, Turner CL, Smith C, et al. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. The Lancet. Neurology, 2014.PMID 24837690